volume 3, issue 2, P144-153 2010
DOI: 10.15283/ijsc.2010.3.2.144
View full text

Abstract: Background and Objectives: In the last few years, treatment protocols using mesenchymal stem cells (MSC) in various experimental models and human diseases have been investigated. MSCs are on the focus of stem cell research, since they are considered as a type of adult stem cells with low toxicity and acceptable side effects profile and they can be administered autologously. In addition several studies have revealed significant immunomodulatory properties of MSCs and a potential for transdifferentiation, inclu…

Expand abstract